AIRNA Closes $60M Series A Round to Advance RNA Editing Therapeutics
Key Highlights AIRNA secures $60M in oversubscribed Series A financing. Funding led by Forbion with key investments from…
Browsing Tag
ARCH Venture Partners
4 posts
Xaira Therapeutics Launches with $1 Billion to Innovate Drug Discovery
Key Highlights $1 Billion Capital Commitment: Backed by ARCH Venture Partners, Foresite Capital, and others including Sequoia and NEA.…
PureTech Health Advances Strategic Initiatives, Launches Seaport Therapeutics
Key Highlights Seaport Therapeutics launches with $100M in Series A financing to develop neuropsychiatric medicines. Leadership Transition: Daphne Zohar steps…
Areteia Secures $75M for Asthma Drug Expansion
Key Highlights $75 million in additional Series A financing brings total to $425 million for dexpramipexole’s global Phase III…